INS and obesity disorder: In models of high fat–induced obesity, adipocyte COX-2 expression was reported to increase (31), and administration of selective COX-2 inhibitors or global COX-2 gene deletion reduced adipose tissue mass and inflammation and skeletal muscle insulin resistance (31–34).